Global and United States Short Bowel Syndrome (SBS) Drugs Market Insights, Forecast to 2027

Global and United States Short Bowel Syndrome (SBS) Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Short Bowel Syndrome(SBS) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Type
1.2.2 Glucagon-Like Peptide-2(GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market by Sale Channel
1.3.1 Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Sale Channel
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Short Bowel Syndrome(SBS) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Short Bowel Syndrome(SBS) Drugs Revenue 2016-2027
2.1.2 Global Short Bowel Syndrome(SBS) Drugs Sales 2016-2027
2.2 Global Short Bowel Syndrome(SBS) Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Short Bowel Syndrome(SBS) Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Short Bowel Syndrome(SBS) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Short Bowel Syndrome(SBS) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Short Bowel Syndrome(SBS) Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Region (2022-2027)
3 Global Short Bowel Syndrome(SBS) Drugs Competitor Landscape by Players
3.1 Global Top Short Bowel Syndrome(SBS) Drugs Manufacturers by Sales
3.1.1 Global Short Bowel Syndrome(SBS) Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Short Bowel Syndrome(SBS) Drugs Manufacturers by Revenue
3.2.1 Key Short Bowel Syndrome(SBS) Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Short Bowel Syndrome(SBS) Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Short Bowel Syndrome(SBS) Drugs Revenue in 2020
3.2.6 Global Short Bowel Syndrome(SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Short Bowel Syndrome(SBS) Drugs Price by Manufacturers
3.4 Global Short Bowel Syndrome(SBS) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Short Bowel Syndrome(SBS) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Short Bowel Syndrome(SBS) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Short Bowel Syndrome(SBS) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Short Bowel Syndrome(SBS) Drugs Market Size by Type (2016-2021)
4.1.1 Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2016-2021)
4.1.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2016-2021)
4.1.3 Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Short Bowel Syndrome(SBS) Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Sale Channel (2016-2027)
5.1 Global Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel (2016-2021)
5.1.1 Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2016-2021)
5.1.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2016-2021)
5.1.3 Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2016-2021)
5.2 Short Bowel Syndrome(SBS) Drugs Market Size Forecast by Sale Channel (2022-2027)
5.2.1 Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Sale Channel (2022-2027)
5.2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Sale Channel (2022-2027)
5.2.3 Global Short Bowel Syndrome(SBS) Drugs Price Forecast by Sale Channel (2022-2027)
6 United States by Players, Type and Sale Channel
6.1 United States Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Short Bowel Syndrome(SBS) Drugs Sales YoY Growth 2016-2027
6.1.2 United States Short Bowel Syndrome(SBS) Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Short Bowel Syndrome(SBS) Drugs Market Share in Global Market 2016-2027
6.2 United States Short Bowel Syndrome(SBS) Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Short Bowel Syndrome(SBS) Drugs Players by Sales (2016-2021)
6.2.2 United States Top Short Bowel Syndrome(SBS) Drugs Players by Revenue (2016-2021)
6.3 United States Short Bowel Syndrome(SBS) Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Short Bowel Syndrome(SBS) Drugs Price by Type (2016-2021)
6.4 United States Short Bowel Syndrome(SBS) Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Short Bowel Syndrome(SBS) Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Short Bowel Syndrome(SBS) Drugs Price Forecast by Type (2022-2027)
6.5 United States Short Bowel Syndrome(SBS) Drugs Historic Market Review by Sale Channel (2016-2021)
6.5.1 United States Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2016-2021)
6.5.2 United States Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2016-2021)
6.5.3 United States Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2016-2021)
6.6 United States Short Bowel Syndrome(SBS) Drugs Market Estimates and Forecasts by Sale Channel (2022-2027)
6.6.1 United States Short Bowel Syndrome(SBS) Drugs Sales Forecast by Sale Channel (2022-2027)
6.6.2 United States Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Sale Channel (2022-2027)
6.6.3 United States Short Bowel Syndrome(SBS) Drugs Price Forecast by Sale Channel (2022-2027)
7 North America
7.1 North America Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2016-2027
7.2 North America Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country
7.2.1 North America Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021)
7.2.2 North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2016-2027
9.2 Europe Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country
9.2.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021)
9.2.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country
10.2.1 Latin America Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021)
10.2.2 Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Short Bowel Syndrome(SBS) Drugs Products Offered
12.1.5 Merck Recent Development
12.2 Takeda
12.2.1 Takeda Corporation Information
12.2.2 Takeda Description and Business Overview
12.2.3 Takeda Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Takeda Short Bowel Syndrome(SBS) Drugs Products Offered
12.2.5 Takeda Recent Development
12.3 Emmaus Medical
12.3.1 Emmaus Medical Corporation Information
12.3.2 Emmaus Medical Description and Business Overview
12.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Products Offered
12.3.5 Emmaus Medical Recent Development
12.4 Ardelyx
12.4.1 Ardelyx Corporation Information
12.4.2 Ardelyx Description and Business Overview
12.4.3 Ardelyx Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ardelyx Short Bowel Syndrome(SBS) Drugs Products Offered
12.4.5 Ardelyx Recent Development
12.5 Naia Pharmaceuticals
12.5.1 Naia Pharmaceuticals Corporation Information
12.5.2 Naia Pharmaceuticals Description and Business Overview
12.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Products Offered
12.5.5 Naia Pharmaceuticals Recent Development
12.6 Nutrinia
12.6.1 Nutrinia Corporation Information
12.6.2 Nutrinia Description and Business Overview
12.6.3 Nutrinia Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Nutrinia Short Bowel Syndrome(SBS) Drugs Products Offered
12.6.5 Nutrinia Recent Development
12.7 OxThera
12.7.1 OxThera Corporation Information
12.7.2 OxThera Description and Business Overview
12.7.3 OxThera Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 OxThera Short Bowel Syndrome(SBS) Drugs Products Offered
12.7.5 OxThera Recent Development
12.8 Sancilio Pharmaceuticals
12.8.1 Sancilio Pharmaceuticals Corporation Information
12.8.2 Sancilio Pharmaceuticals Description and Business Overview
12.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Products Offered
12.8.5 Sancilio Pharmaceuticals Recent Development
12.9 Zealand Pharma
12.9.1 Zealand Pharma Corporation Information
12.9.2 Zealand Pharma Description and Business Overview
12.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Products Offered
12.9.5 Zealand Pharma Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Short Bowel Syndrome(SBS) Drugs Products Offered
12.11.5 Merck Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Short Bowel Syndrome(SBS) Drugs Industry Trends
13.2 Short Bowel Syndrome(SBS) Drugs Market Drivers
13.3 Short Bowel Syndrome(SBS) Drugs Market Challenges
13.4 Short Bowel Syndrome(SBS) Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Short Bowel Syndrome(SBS) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Glucagon-Like Peptide-2(GLP-2)
Table 3. Major Manufacturers of Growth Hormone
Table 4. Major Manufacturers of Glutamine
Table 5. Major Manufacturers of Other
Table 6. Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Sale Channel (2021-2027) & (K Pcs)
Table 7. Global Short Bowel Syndrome(SBS) Drugs Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Short Bowel Syndrome(SBS) Drugs Sales by Regions (2016-2021) & (K Pcs)
Table 9. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Short Bowel Syndrome(SBS) Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 12. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Short Bowel Syndrome(SBS) Drugs Sales by Manufacturers (2016-2021) (K Pcs)
Table 16. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Short Bowel Syndrome(SBS) Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Short Bowel Syndrome(SBS) Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Short Bowel Syndrome(SBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Short Bowel Syndrome(SBS) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome(SBS) Drugs as of 2020)
Table 22. Key Manufacturers Short Bowel Syndrome(SBS) Drugs Price (2016-2021) (USD/Pcs)
Table 23. Short Bowel Syndrome(SBS) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Short Bowel Syndrome(SBS) Drugs Product Type
Table 25. Date of International Manufacturers Enter into Short Bowel Syndrome(SBS) Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2016-2021) (K Pcs)
Table 28. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Type (2016-2021)
Table 29. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Type (2016-2021)
Table 31. Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 32. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 33. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 37. Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2016-2021) (K Pcs)
Table 38. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Sale Channel (2016-2021)
Table 39. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2016-2021) (US$ Million)
Table 40. Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Sale Channel (2016-2021)
Table 41. Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) by Sale Channel (2016-2021) & (USD/Pcs)
Table 42. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Sale Channel (2022-2027) & (K Pcs)
Table 43. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Forecast by Sale Channel (2022-2027)
Table 44. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Sale Channel (2022-2027) & (US$ Million)
Table 45. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Sale Channel (2022-2027)
Table 46. Global Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) Forecast by Sale Channel (2022-2027) & (USD/Pcs)
Table 47. United States Short Bowel Syndrome(SBS) Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 48. United States Short Bowel Syndrome(SBS) Drugs Sales Share by Company (2016-2021)
Table 49. United States Short Bowel Syndrome(SBS) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Short Bowel Syndrome(SBS) Drugs Revenue Share by Company (2016-2021)
Table 51. United States Short Bowel Syndrome(SBS) Drugs Sales (K Pcs) by Type (2016-2021)
Table 52. United States Short Bowel Syndrome(SBS) Drugs Sales Share by Type (2016-2021)
Table 53. United States Short Bowel Syndrome(SBS) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Short Bowel Syndrome(SBS) Drugs Price (USD/Pcs) by Type (2016-2021)
Table 55. United States Short Bowel Syndrome(SBS) Drugs Sales (K Pcs) by Type (2022-2027)
Table 56. United States Short Bowel Syndrome(SBS) Drugs Sales Share by Type (2022-2027)
Table 57. United States Short Bowel Syndrome(SBS) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Short Bowel Syndrome(SBS) Drugs Revenue Share by Type (2022-2027)
Table 59. United States Short Bowel Syndrome(SBS) Drugs Price (USD/Pcs) by Type (2022-2027)
Table 60. United States Short Bowel Syndrome(SBS) Drugs Sales (K Pcs) by Sale Channel (2016-2021)
Table 61. United States Short Bowel Syndrome(SBS) Drugs Sales Share by Sale Channel (2016-2021)
Table 62. United States Short Bowel Syndrome(SBS) Drugs Revenue (US$ Million) Market Share by Sale Channel (2016-2021)
Table 63. United States Short Bowel Syndrome(SBS) Drugs Price (USD/Pcs) by Sale Channel (2016-2021)
Table 64. United States Short Bowel Syndrome(SBS) Drugs Sales (K Pcs) by Sale Channel (2022-2027)
Table 65. United States Short Bowel Syndrome(SBS) Drugs Sales Share by Sale Channel (2022-2027)
Table 66. United States Short Bowel Syndrome(SBS) Drugs Revenue (US$ Million) Market Share by Sale Channel (2022-2027)
Table 67. United States Short Bowel Syndrome(SBS) Drugs Revenue Share by Sale Channel (2022-2027)
Table 68. United States Short Bowel Syndrome(SBS) Drugs Price (USD/Pcs) by Sale Channel (2022-2027)
Table 69. North America Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 70. North America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Region (2016-2021) & (K Pcs)
Table 74. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 78. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 82. Latin America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 86. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2016-2021)
Table 89. Merck Corporation Information
Table 90. Merck Description and Business Overview
Table 91. Merck Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 92. Merck Short Bowel Syndrome(SBS) Drugs Product
Table 93. Merck Recent Development
Table 94. Takeda Corporation Information
Table 95. Takeda Description and Business Overview
Table 96. Takeda Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 97. Takeda Product
Table 98. Takeda Recent Development
Table 99. Emmaus Medical Corporation Information
Table 100. Emmaus Medical Description and Business Overview
Table 101. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 102. Emmaus Medical Product
Table 103. Emmaus Medical Recent Development
Table 104. Ardelyx Corporation Information
Table 105. Ardelyx Description and Business Overview
Table 106. Ardelyx Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 107. Ardelyx Product
Table 108. Ardelyx Recent Development
Table 109. Naia Pharmaceuticals Corporation Information
Table 110. Naia Pharmaceuticals Description and Business Overview
Table 111. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 112. Naia Pharmaceuticals Product
Table 113. Naia Pharmaceuticals Recent Development
Table 114. Nutrinia Corporation Information
Table 115. Nutrinia Description and Business Overview
Table 116. Nutrinia Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 117. Nutrinia Product
Table 118. Nutrinia Recent Development
Table 119. OxThera Corporation Information
Table 120. OxThera Description and Business Overview
Table 121. OxThera Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 122. OxThera Product
Table 123. OxThera Recent Development
Table 124. Sancilio Pharmaceuticals Corporation Information
Table 125. Sancilio Pharmaceuticals Description and Business Overview
Table 126. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 127. Sancilio Pharmaceuticals Product
Table 128. Sancilio Pharmaceuticals Recent Development
Table 129. Zealand Pharma Corporation Information
Table 130. Zealand Pharma Description and Business Overview
Table 131. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 132. Zealand Pharma Product
Table 133. Zealand Pharma Recent Development
Table 134. Short Bowel Syndrome(SBS) Drugs Market Trends
Table 135. Short Bowel Syndrome(SBS) Drugs Market Drivers
Table 136. Short Bowel Syndrome(SBS) Drugs Market Challenges
Table 137. Short Bowel Syndrome(SBS) Drugs Market Restraints
Table 138. Short Bowel Syndrome(SBS) Drugs Customers List
Table 139. Short Bowel Syndrome(SBS) Drugs Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome(SBS) Drugs Product Picture
Figure 2. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Glucagon-Like Peptide-2(GLP-2) Product Picture
Figure 4. Growth Hormone Product Picture
Figure 5. Glutamine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Retail Pharmacies
Figure 11. Short Bowel Syndrome(SBS) Drugs Report Years Considered
Figure 12. Global Short Bowel Syndrome(SBS) Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Short Bowel Syndrome(SBS) Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Short Bowel Syndrome(SBS) Drugs Sales 2016-2027 (K Pcs)
Figure 15. Global Short Bowel Syndrome(SBS) Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region in 2020
Figure 18. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region in 2020
Figure 20. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Short Bowel Syndrome(SBS) Drugs Revenue in 2020
Figure 22. Short Bowel Syndrome(SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2016-2021)
Figure 24. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type in 2020
Figure 25. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2016-2021)
Figure 26. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type in 2020
Figure 27. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2016-2021)
Figure 28. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel in 2020
Figure 29. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2016-2021)
Figure 30. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel in 2020
Figure 31. United States Short Bowel Syndrome(SBS) Drugs Sales Growth Rate 2016-2027 (K Pcs)
Figure 32. United States Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Short Bowel Syndrome(SBS) Drugs Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Short Bowel Syndrome(SBS) Drugs Players Market Share by Revenue in Short Bowel Syndrome(SBS) Drugs in 2020
Figure 35. United States Short Bowel Syndrome(SBS) Drugs Revenue Share by Type (2016-2021)
Figure 36. United States Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Short Bowel Syndrome(SBS) Drugs Revenue Share by Sale Channel (2016-2021)
Figure 38. United States Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate by Sale Channel in 2016 & 2020
Figure 39. North America Short Bowel Syndrome(SBS) Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 40. North America Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2020
Figure 42. North America Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2020
Figure 43. U.S. Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 44. U.S. Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 46. Canada Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Short Bowel Syndrome(SBS) Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 48. Europe Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2020
Figure 50. Europe Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2020
Figure 51. Germany Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. Germany Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. France Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. U.K. Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Italy Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. Russia Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 62. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region in 2020
Figure 64. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region in 2020
Figure 65. China Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. China Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. Japan Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Short Bowel Syndrome(SBS) Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. South Korea Short Bowel Synd

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs